Next-Generation Cancer Diagnostics: Technologies and Global Markets

Next-Generation Cancer Diagnostics: Technologies and Global Markets
The total annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.
Learn about the status of next generation cancer diagnostic technologies and assays, and assess their worldwide growth potential over a 5-year period from 2010 to 2015. Influencing factors, including cancer diagnostics needs, regulatory trends, industry structure, and patent status are also discussed...
Use this report to:

• Characterize the markets for the key next generation platforms: real time polymerase chain reaction, DNA microarrays, lab-on-a-chip, protein microarrays, circulating tumor cells, and multiplexed conventional and next generation sequencing.
• Understand the trends, markets, applications, industry dynamics, and the forces driving industry growth as the basis for effective strategy development.
• Evaluate market opportunities and future growth of specific cancer diagnostic market segments to validate or formulate business development plans.
• Analyze the impact of recent corporate acquisitions and alliances with the potential to change the industry structure and competitive landscape.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

SUMMARY FIGURE

GLOBAL VALUE OF NEXT GENERATION CANCER DIAGNOSTICS BY ANALYSIS TYPE, 2009-2015

($ MILLIONS)